27 unknown, 17 completed, 9 recruiting, 5 active not recruiting. 23 Not applicable, 17 Phase 4, 5 Phase 2, 5 Phase 3, 1 Phase 1.
Follow E-DA Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Real-Time Magnetic Device Prototype for Temporary Management of Paralytic Lagophthalmos Magnetic device prototype - Paralytic Lagophthalmos | Not applicable | Suspended | E-DA Hospital | 12 | 2026-08-01 | 2025-08-14 |
| Exploring the Effectiveness of an Application Intervention on Cognitive, Learning Self-Efficacy,and Clinical Reasoning of Nurses Regarding Delirium Education in the Intensive Care Unit Application Intervention - Cognitive of Delirium, Learning Self-Efficacy of Delirium | Not applicable | Completed | Ping-Chiao Chung | 102 | 2026-02-09 | 2026-08-12 |
| Effects of Jive Dance Training on Lower Limb Muscle Strength Systematic Solo Jive Dance Training - Workplace Health Promotion, Muscle Strength | Not applicable | Active not recruiting | E-DA Hospital | 20 | 2025-10-21 | 2026-06-11 |
| Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma | Completed | National Taiwan University Hospital | 243 | 2025-07-17 | 2026-10-09 | |
| Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers Jing Si Herbal Tea - Dementia, Caregiver Burden | Not applicable | Recruiting | National Cheng Kung University | 400 | 2025-01-17 | 2026-04-13 |
| Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease Carvedilol - Portal Hypertension, Hepatic Decompensation | Phase 4 | Recruiting | Chinese University of Hong Kong | 474 | 2024-07-17 | 2026-10-22 |
| Clinical Outcomes Of Mega-dosage Supplementations Of Cholecalciferol In Critically Ill Patients With Sepsis Placebo, Cholecalciferol - Critically Ill, Sepsis | Not applicable | Not yet recruiting | Chimei Medical Center | 240 | 2024-07-01 | 2024-06-17 |
| Risk Factors Affect Weight Loss Outcomes After Treatment. Weight Regain | Completed | E-DA Hospital | 3602 | 2024-06-27 | 2026-01-06 | |
| Taiwan Interstitial Lung Disease Multi-center Investigation and Registry Interstitial Lung Disease, Comorbidities and Coexisting Conditions | Recruiting | Taichung Veterans General Hospital | 10000 | 2024-03-10 | 2024-06-26 | |
| Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial 4-month regimen (2HERZ/2HRE), 6-month (2HERZ/4HRE) - Pulmonary Tuberculosis | Phase 3 | Recruiting | Kaohsiung Veterans General Hospital. | 270 | 2024-01-01 | 2026-08-03 |
| Taiwan Severe Asthma Biologic Registry Biological Treatment for severe asthma patients - Pulmonary Disease, Asthma | Recruiting | Taichung Veterans General Hospital | 500 | 2023-11-11 | 2026-05-19 | |
| Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision Artificial intelligence, Endocuff vision, High-definition endoscope - Adenoma Detection Rate | Not applicable | Recruiting | E-DA Hospital | 1000 | 2023-05-02 | 2025-06-27 |
| 2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy 2% Lidocaine Gel, Water-based Lubricant Gel (K-Y Gel), Standard Postoperative Analgesics - Surgery, Pain, Postoperative | Not applicable | Unknown | E-DA Hospital | 400 | 2023-05-01 | 2024-06-12 |
| Ice Therapy and Warm Baths for Hemorrhoidectomy Wound Care Ice packing, Warm sitz bath - Post Hemorrhoidectomy Pain, Post Operative Pain | Not applicable | Unknown | E-DA Hospital | 120 | 2023-05-01 | 2024-06-14 |
| A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis Feedback-enabled magnetic device - Blepharoptosis, Device Usability | Not applicable | Recruiting | E-DA Hospital | 40 | 2023-04-01 | 2026-09-23 |
| The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE One biopsy, Three biopsy, Seattle protocol - Barrett's Esophagus, Intestinal Metaplasia | Not applicable | Recruiting | E-DA Hospital | 165 | 2023-03-13 | 2023-05-11 |
| Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B Nuc Discontinuation, Entecavir or Tenofovir - Chronic Hepatitis b | Not applicable | Active not recruiting | E-DA Hospital | 360 | 2022-12-20 | 2023-03-31 |
| Naldebain for Control of Post-Cesarean Section Pain Patient-controlled epidural analgesia (PCEA), Naldebain® - Post Operative Pain, Acute, Post Operative Pain, Chronic | Phase 2 | Unknown | E-DA Hospital | 120 | 2022-09-01 | 2022-04-08 |
| Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study Comparison of ADR - Adenoma Detection Rate, Colonoscopy | Completed | Evergreen General Hospital, Taiwan | 2707 | 2021-11-20 | 2026-09-11 | |
| Naldebain for Pain Management of Laparoscopic Cholecystectomy Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic | Phase 2 / Phase 3 | Completed | E-DA Hospital | 80 | 2021-08-30 | 2022-04-20 |
Showing 20 of 63. Sign in to see all of them.
Hepatitis B, Chronic (5) · Pain, Postoperative (5) · Tuberculosis (3) · Carcinoma, Hepatocellular (2) · Chronic Pain (2) · Esophageal Neoplasms (2) · Hemorrhoids (2) · Hepatitis B (2) · Obesity (2) · Patient Compliance (2) · Renal Insufficiency, Chronic (2) · Stroke (2) · Acquired Immunodeficiency Syndrome (1) · Agnosia (1) · Anemia (1)
Carvedilol (3) · Tenofovir (3) · sebacoyl dinalbuphine ester (3) · Endoscopy (2) · tenofovir alafenamide (2) · Amoxicillin (1) · Atorvastatin (1) · Botulinum Toxins, Type A (1) · Central Venous Catheters (1) · Chlorhexidine (1) · Cholecalciferol (1) · Cilostazol (1) · Clinical Protocols (1) · Dabigatran (1) · Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)
Taiwan (55) · United States (2) · Hong Kong (1) · South Korea (1)
Chen-Fuh Lam, MD, PhD (3) · Ting-Hsing Chao, MD (2) · Chen Chih-I (1) · Chen Li-Tzong (1) · Chi-Liang Cheng (1) · Chia-Jui Yang, MD (1) · Chien-Chin Hung, PHD (1) · Chien-Ching Hung (1) · Chih-Kun Huang, Doctor (1) · Chin Ming Chen (1) · Chun-An Chen, MD, PhD (1) · Chung Y. Hsu, MD. Ph.D. (1) · Han-Mo Chiu, MD (1) · Hao-Ming Li, MD (1) · Jau-Hong Lin, Professor (1)
PMID 11474389, PMID 12297767, PMID 16344051, PMID 18045592, PMID 18360296, PMID 19012761, PMID 19268726, PMID 19340732, PMID 19474425, PMID 20557380, PMID 20669074, PMID 21455869, PMID 21679712, PMID 21839994, PMID 21997553, PMID 22423666, PMID 23618821, PMID 24165758, PMID 24246797, PMID 24556051, PMID 24668102, PMID 25257127, PMID 25668428, PMID 26106962, PMID 26260107, PMID 26656367, PMID 26832653, PMID 26927298, PMID 28385543, PMID 28753699, PMID 28780072, PMID 28981543, PMID 29846605, PMID 30012433, PMID 31765987, PMID 32118788, PMID 32289853, PMID 32519889, PMID 33273214, PMID 33524314, PMID 33618027, PMID 33895358, PMID 35354777, PMID 35972481, PMID 36960779, PMID 38245785, PMID 38291459, PMID 38582493, PMID 38583540, PMID 39415599